The 99 references in paper Ya. Zverev F., V. Bryukhanov M., Я. Зверев Ф., В. Брюханов М. (2006) “О ФУНКЦИОНАЛЬНОЙ РОЛИ ЦЕНТРАЛЬНЫХ МИНЕРАЛОКОРТИКОИДНЫХ РЕЦЕПТОРОВ И ВОЗМОЖНОСТЯХ ИХ ФАРМАКОЛОГИЧЕСКОЙ РЕГУЛЯЦИИ // ON THE FUNCTIONAL ROLE OF CENTRAL MINERALOCORTICOID RECEPTORS AND POSSIBILITIES OF THEIR PHARMACOLOGICAL REGULATION” / spz:neicon:nefr:y:2006:i:1:p:14-24

1
Brilla CG, Schencking M, Scheer C, Rupp H. Spironolactone: renaissance of anti-aldosterone therapy in heart failure? Schweiz Rundsch Med Prax 1997; 86 (14): 566-574
(check this in PDF content)
2
Моисеев СВ. Спиронолактон (альдактон) в лечении сердечной недостаточности (исследование RALES). Клин фармакол и терап 1999; 8 (6): 46-51
(check this in PDF content)
3
Зверев ЯФ, Брюханов ВМ. Спиронолактон в комплек­ 21 сной терапии хронической сердечной недостаточности. Со­ временные патогенетические подходы. Клинич фармакол и терап 2000; 9 (4): 46-52
(check this in PDF content)
4
Зверев ЯФ, Брюханов ВМ. Фармакология и клини­ ческое использование экстраренального действия диуре­ тиков. Медицинская книга, М., Изд-во НГМА, Н.Новгород, 2000; 61-81
(check this in PDF content)
5
Stier CTJr, Koenig S, Lee DY et al. Aldosterone and aldosterone antagonism in cardiovascular disease: focus on eplerenone (Inspra). Heart Dis 2003; 5 (2): 102-118
(check this in PDF content)
6
Brennan BJ, Martin NE. Eplerenone: selective aldosterone antagonism in management of cardiovascular and renal disease. J Am Pharm Assoc (Wash DC) 2004; 44 (5): 604-610
(check this in PDF content)
7
Jackiewicz E, Szczepanska-Sadowska E, Maslinski W. Expression of mineralocorticoid receptors mRNA in the brain, heart and kidney of Sprague Dawley rats with renovascular hypertension. Brain Res Bull 2005; 65 (1): 23-29
(check this in PDF content)
8
Stier CTJr, Rocha R, Chander PN. Effect of aldosterone and MR blockade on the brain and the kidney. Heart Fail Rev 2005; 10 (1): 53-62
(check this in PDF content)
9
Luttge WG, Rupp ME, Davda MM. Aldosterone- stimulated down-regulation of both type I and II adrenocorticosteroid receptors in mouse brain is mediated via type I receptors. Endocrinology 1989; 125 (2): 817-824
(check this in PDF content)
10
Agarwal MK, Mirshahi F, Mirshahi M, Rostene W. Immunochemical detection of mineralocorticoid receptor in rat brain. Neuroendocrinology 1993; 58 (5): 575-580
(check this in PDF content)
11
Sanchez MM, Young LJ, Plotsky PM, Insel TR. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 2000; 20 (12): 4657-4668
(check this in PDF content)
12
Kretz O, Schmid W, Berger S, Gass P The mineralocorticoid receptor expression in the mouse CNS is conserved during development. Neuroreport 2001; 12 (6): 1133-1137
(check this in PDF content)
13
Hansson AC, Fuxe K. Biphasic autoregulation of mineralocorticoid receptor mRNA in the medial septal nucleus by aldosterone. Neuroendocrinology 2002; 75 (6): 358-366
(check this in PDF content)
14
Kloet ER, Van Acker SA, Sibug RM et al. Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 2000; 57 (4): 1329-1336
(check this in PDF content)
15
Datson NA, van der Perk J, de Kloet ER, Vreugdenhil E. Identification of corticosteroid-responsive genes in rat hyppocampus using serial analysis of gene expression. Eur J Neurosci 2001; 14 (4): 675-689
(check this in PDF content)
16
Funder JW, Sheppard K. Adrenocortical steroids and the brain. Annu Rev Physiol 1987; 49: 397-411
(check this in PDF content)
17
Oitzl MS, Fluttert M, de Kloet ER. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur J Neurosci 1994; 6 (7): 1072-1079
(check this in PDF content)
18
Kalman BA, Spencer RL. Rapid corticosteroid- dependent regulation of mineralocorticoid receptor protein expression in rat brain. Endocrinology 2002; 143 (11): 4184­ 4195
(check this in PDF content)
19
Арушанян ЭБ, Бейер ЭВ. Место гиппокампа в био­ ритмологической организации поведения. Успехи физиол наук 2001; 32 (1): 79-95
(check this in PDF content)
20
Чирков АМ, Цулая МГ, Чиркова СК и др. Психофар­ макология эмоционального стресса у обезьян. Изд-во Мец- ниереба, Тбилиси, 1989; 245-315
(check this in PDF content)
21
Филаретов АА. Закономерности функционирования гипоталамо-гипофизарно-адренокортикальной системы. Успехи физиол наук 1993; 24 (2): 70-83
(check this in PDF content)
22
Арушанян ЭБ. Хронофармакология. Изд-во СГМА, Ставрополь, 1999; 14-27, 75-85
(check this in PDF content)
23
Deuschle M, Weber B, Colla M et al. Mineralocorticoid receptor also modulates basal activity of hypothalamus- pituitary-adrenocortical system in humans. Neuroendocrinology 1998; 68 (5): 355-360
(check this in PDF content)
24
Arvat E, Maccagno B, Giordano R et al. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans. J Clin Endocrinol Metab 2001; 86 (7): 3176-3181
(check this in PDF content)
25
Ratka A, Sutanto W, Bloemers M, de Kloet ER. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 1989; 50 (2): 117-123
(check this in PDF content)
26
Young EA, Lopez JF, Murphy Weinberg V et al. The role of mineralocorticoid receptors in hypothalamic-pituitary- adrenal axis regulation in humans. J Clin E ndocrinol Metab 1998; 83 (9): 3339-3345
(check this in PDF content)
27
Heuser I, Deuschle M, Weber A et al. The role of mineralocorticoid receptors in the circadian activity of the human hypothalamus-pituitary-adrenal system: effect of age. Neurobiol Aging 2000; 21 (4): 585-589
(check this in PDF content)
28
Haarst AD, Oitzl MS, de Kloet ER. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurochem Res 1997; 22 (11): 1323-1328
(check this in PDF content)
29
Spencer RL, Kim PJ, Kalman BA, Cole MA. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary- adrenal axis activity. Endocrinology 1998; 139 (6): 2718-2726
(check this in PDF content)
30
Cole MA, Kim PJ, Kalman BA, Spencer RL. Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies. Psychoneuroendocrinology 2000; 25 (2): 151-167
(check this in PDF content)
31
Schmidt M, Oitzl MS, Muller MB et al. Regulation of the developing hypothalamic-pituitary-adrenal axis in corticotropin releasing hormone receptor 1-deficient mice. Neuroscience 2003; 119 (2): 589-595
(check this in PDF content)
32
Schmidt MV, Levine S, Oitzl MS et al. Glucocorticoid receptor blockade disinhibits pituitary-adrenal activity during the stress hyporesponsive period of the mouse. Endocrinology 2005; 146 (3): 1458-1464
(check this in PDF content)
33
Kloet ER. Stress in the brain. Eur J Pharmacol 2000; 405 (1-3): 187-198
(check this in PDF content)
34
Nishi M, Kawata M. Corticosteroid receptor and stress. Nihon Shinkei Seishin Yakurigaku Zasshi 2000; 20 (5): 181-188
(check this in PDF content)
35
Joles M. Corticosteroid actions in the hippocampus. J Neuroendocrinol 2001; 13 (8): 657-669
(check this in PDF content)
36
Buuse M, van Acker SA, Fluttert MF, de Kloet ER. Involvement of corticosterone in cardiovascular responses to an open-field novelty stressor in freely moving rats. Physiol Behav 2002; 75 (1-2):207-215
(check this in PDF content)
37
Kloet ER. Hormones, brain and stress. Endocr Regul 2003; 37 (2): 51-68
(check this in PDF content)
38
Kloet ER. Hormones and the stressed brain. Ann NY Acad Sci 2004; 1018: 1-15
(check this in PDF content)
39
Kloet ER, Derijk R. Signaling pathways in brain involved in predisposition and pathogenesis of stress-related disease: genetic and kinetic factors affecting the MR/GR balance. Ann NY Acad Sci 2004; 1032: 14-34
(check this in PDF content)
40
Takeda H, Tsuji M, Matsumiya T. Formation mechanisms of stress adaptation: role of functional coupling of glucocorticoids and brain serotonergic nervous system. Nihon Shinkei Seishin Yakurigaku Zasshi 2000; 20 (3): 83-91
(check this in PDF content)
41
Young EA, Lopez JF, Murphy-Weinberg V et al. Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 2003; 60 (1): 24-28
(check this in PDF content)
42
Xing GQ, Russel S, Webster MJ, Post RM. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorders. In t Neuropsychopharmacol 2004; 7 (2): 143-153
(check this in PDF content)
43
Herman JP, Spencer R. Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo. J Neurosci 1998; 18 (18): 7462-7473
(check this in PDF content)
44
Nishi M, Takeda M, Matsuda K et al. Visualization of glucocorticoid receptor and mineralocorticoid receptor interactions in living cells with GFP-based fluorescence resonance energy transfer. J Neurosci 2004; 24 (21): 4918-4927
(check this in PDF content)
45
Cole MA, Kalman BA, Pace TW et al. Selective blockade of the mineralocorticoid receptor impairs hypothalamic- pituitary-adrenal axis expression of habituation. Neuroendocrinol 2000; 12 (10): 1034-1042
(check this in PDF content)
46
Виноградова ОС. Гиппокамп и память. Наука, М., 1975; 81-156
(check this in PDF content)
47
Vanderwolf C, Kelly M, Kraemer P, Streather A. Are emotion and motivation localized in the limbic system and nucleus accumbens? Behav Brain Res 1988; 27 (1): 45-58
(check this in PDF content)
48
Симонов ПВ. О нервных центрах эмоций. Журн высш нервн деят 1993; 43 (3): 514-529
(check this in PDF content)
49
Симонов ПВ. Мозговые механизмы эмоций. Журн высш нервн деят 1997; 47 (2): 320-328
(check this in PDF content)
50
Туманян ВА. Активность нейронов гиппокампа и ви­ сочной коры в процессе обучения. Изд-во АН Армянской ССР, Ереван, 1988; 85-180
(check this in PDF content)
51
Haller J, Millar S, Kruk MR. Mineralocorticoid receptor blockade inhibits aggressive behaviour in male rats. Stress 1998; 2 (3): 201-207
(check this in PDF content)
52
Haller J, Millar S, van de Schraaf J et al. The active phase-related increase in corticosterone and aggression are linked. J Neuroendocrinol 2000; 12 (5): 431-436
(check this in PDF content)
53
Korte SM, de Boer SF, de Kloet ER, Bohus B. Anxiolytic­ like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus- maze. Psychoneuroendocrinology 1995; 20 (4): 385-394
(check this in PDF content)
54
Bitran D, Shiekh M, Dowd JA et al. Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors. Pharm acol Biochem Behav 1998; 60 (4): 879-887
(check this in PDF content)
55
Smythe JW, Murphy D, Timothy C, Costall B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharm acol Biochem Behav 1997; 56 (3): 507-513
(check this in PDF content)
56
Murphy D, Costall B, Smythe JW. Regulation of hippocampal theta activity by corticosterone: opposing functions of mineralocorticoid and glucocorticoid receptors. Brain Res Bull 1998; 45 (6): 631-635
(check this in PDF content)
57
Douma BR, Jansen K, Korte SM et al. Corticosterone modifies muscarinic receptor immunoreactivity in rat hippocampus. Neurosci Lett 1999; 268 (1): 41-44
(check this in PDF content)
58
Meijer OC, Williamson A, Dallman MF, Pearce D. Transcriptional repression of the 5-HT1A receptor promoter by corticosterone via mineralocorticoid receptors depends on the cellular context. J Neuroendocrinol 2000; 12 (3): 245-254
(check this in PDF content)
59
Wissink S, Meijer O, Pearce D et al. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J Biol Chem 2000; 275 (2): 1321-1326
(check this in PDF content)
60
Joels M, Van Riel E. Mineralocorticoid and glucocorticoid receptor-mediated effects of serotonergic transmission in health and disease. Ann NY Acad Sci 2004; 1032: 301-303
(check this in PDF content)
61
Mitchell JB, Betito K, Rowe W et al. Serotonergic regulation of type II corticosteroid receptor binding in hippocampal cell cultures: evidence for the importance of serotonin-induced changes in cAMP levels. Neuroscience 1992; 48 (3): 631-639
(check this in PDF content)
62
Lai M, McCormick JA, Chapman KE et al. Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal cultures. Neuroscience 2003; 118 (4): 975-984
(check this in PDF content)
63
Yau JL, Hibberd C, Noble J, Seckl JR. The effect of chronic fluoxetine treatment of brain corticosteroid receptor mRNA expression and spatial memory in young and aged rats. Brain Res 2002; 106 (1-2): 117-123
(check this in PDF content)
64
Buwalda B, de Boer SF, Schmidt ED et al. Long-lasting deficient dexamethasone suppression of hypothalamic- pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats. J Neuroendocrinol 1999; 11 (7): 513-520
(check this in PDF content)
65
Okugawa G, Omori K, Suzukawa J et al. Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurons. J Neuroendocrinol 1999; 11 (11): 887-895
(check this in PDF content)
66
Heuser I, Deuschle M, Weber B et al. Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 2000; 25 (5): 513-518
(check this in PDF content)
67
Reul JM, Gesing A, Droste S et al. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur J Pharmacol 2000; 405 (1-3): 235-249
(check this in PDF content)
68
Gesing A, Bilang-Bleuel A, Droste SK et al. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotrophin-releasing hormone. J Neurosci 2001; 21 (13): 4822-4829
(check this in PDF content)
69
Meyer U, van Kampen M, Isovich E et al. Chronic psychosocial stress regulates the expression of both GR and MR mRNA in the hippocampal formation of tree shrews. Hippocampus 2001; 11 (3): 329-336
(check this in PDF content)
70
Keck ME, Wigger A, Welt T et al. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 2002; 26 (1): 94-105
(check this in PDF content)
71
Smriga M, Nishiyama N, Saito H. Mineralocorticoid receptor-mediated enhancement of neuronal excitability and synaptic plasticity in the dentate gyrus in vivo is dependent on the beta-adrenergic activity. J Neurosci Res 1998; 51 (5): 593-601
(check this in PDF content)
72
Huang BS, Leenen FH. Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am J Physiol Heart Circ Physiol 2005; 288 (5): H2491-H2497
(check this in PDF content)
73
Lupien SJ, Wilkinson CW, Briere S et al. The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology 2002; 27 (3): 401-416
(check this in PDF content)
74
Meijer OC, Topic B, Steenbergen PJ et al. Correlations between hypothalamus-pituitary-adrenal axis parameters depend on age and learning capacity. Endocrinology 2005; 146 (3): 1372-1381
(check this in PDF content)
75
Sandi C, Rose SP. Corticosteroid receptor antagonists are amnestic for passive avoidance learning in day-old chicks. Eur J Neurosci 1994; 6 (8): 1292-1297
(check this in PDF content)
76
Losertales M, Rose SP, Daisley JN, Sandi C. Piracetam facilitates long-term memory for a passive avoidance task in chicks through a mechanism that requires a brain corticosteroid action. Eur J Neurosci 1998; 10 (7): 2238-2243
(check this in PDF content)
77
Douma BR, Korte SM, Buwalda B et al. Repeated blockade of mineralocorticoid receptors, but not of glucocorticoid receptors impairs food rewarded spatial learning. Psychoneuroendocrinology 1998; 23 (1): 33-44
(check this in PDF content)
78
Yau JL, Noble J, Seckl JR. Continuous blockade of brain mineralocorticoid receptors impairs spatial learning in rats. Neurosci Lett 1999; 277 (1): 45-48
(check this in PDF content)
79
Smythe JW, Murphy D, Timothy C et al. Cognitive dysfunctions induced by scopolamine are reduced by systemic or intrahippocampal mineralocorticoid receptors blockade. Pharmacol Biochem Behav 1997; 56 (4): 613-621
(check this in PDF content)
80
Frishman WH, Stier CTJr. Aldosterone and aldosterone antagonism in systemic hypertension. Curr Hypertens Rep 2004; 6 (3): 195-200
(check this in PDF content)
81
Gomez-Sanchez EP. Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease. Curr Opin Nephrol Hypertens 2004; 13 (2): 191-196
(check this in PDF content)
82
Berg DT, de Kloet ER, van Dijken HH, de Jong W. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure. Endocrinology 1990; 126 (1): 118-124
(check this in PDF content)
83
Berg DT, de Jong W, de Kloet ER. Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warning. Am J Physiol 1994; 267 (6): E921-E926
(check this in PDF content)
84
Berg DT, de Kloet ER, de Jong W. Central effects of mineralocorticoid antagonist RU 28318 on blood pressure of DOCA-salt hypertensive rats. Am J Physiol 1994; 267 (6): E927-E933
(check this in PDF content)
85
Rahmouni K, Sibug RM, De Kloet ER et al. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension. Eur J Pharmacol 2002; 436 (3): 207-216
(check this in PDF content)
86
Gomez-Sanchez EP, Fort C, Thwaites D. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol 1992; 262 (1): E96-E99
(check this in PDF content)
87
Young M, Head G, Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 1995; 269 (4): E657-E662
(check this in PDF content)
88
Rahmouni K, Barthelmebs M, Grima M et al. Influence 23 of sodium intake on the cardiovascular and renal effects of brain mineralocorticoid receptor blockade in normotensive rats. J Hypertens 2002; 20 (9): 1829-1834
(check this in PDF content)
89
Gomez-Sanchez EP, Gomez-Sanchez CE. Central hypertensiogenic effects of glycyrrhizic acid and carbenoxolone. Am J Physiol 1992; 263 (6): E1125-E1130
(check this in PDF content)
90
Stienstra CM, Jouls M. Effect of corticosteroid treatment in vitro on adrenalectomy-induced impairment of synaptic transmission in the rat dentate gyrus. J Neuroendocrinol 2000; 12 (3): 199-205
(check this in PDF content)
91
Sousa N, Almeida OF. Corticosteroids: sculptors of the hippocampal formation. Rev Neurosci 2002; 13 (1): 59-84
(check this in PDF content)
92
McCullers DL, Herman JP Mineralocorticoid receptors regulate bcl-2 and p 53 mRNA expression in hippocampus. Neuroreport 1998; 9 (13): 3085-3089
(check this in PDF content)
93
Almeida OF, Condu GL, Crochemore C et al. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J 2000; 14 (5): 779-790
(check this in PDF content)
94
Fischer AK, von Rosenstiel P, Fuchs E et al. The prototypic mineralocorticoid receptor agonist aldosterone influences neurogenesis in the dentate gyrus of the adrenalectomized rat. Brain Res 2002; 947 (2): 290-293
(check this in PDF content)
95
Macleod MR, Johansson IM, Soderstrom I et al. Mineralocorticoid receptor expression and increased survival following neuronal injury. Eur J Neurosci 2003; 17 (8): 1549­ 1555
(check this in PDF content)
96
McCullers DL, Herman JP Adrenocorticosteroid receptor blockade and excitotoxic challenge regulate adrenocorticosteroid receptor mRNA levels in hippocampus. J Neurosci Res 2001; 64 (3): 277-283
(check this in PDF content)
97
McCullers DL, Sullivan PG, Scheff SW, Herman JP Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat. Neuroscience 2002; 109 (2): 219-230
(check this in PDF content)
98
McCullers DL, Sullivan PG, Scheff SW, Herman JP Traumatic brain injury regulates adrenocorticosteroid receptor mRNA levels in rat hippocampus. Brain Res 2002; 947 (1): 41-49
(check this in PDF content)
99
Pedersen WA, McCullers D, Culmsee C et al. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer’s disease. Neurobiol Dis 2001; 8 (3): 492-503 Поступила в редакцию 11.11.2005 г.
(check this in PDF content)